SEC Form 4 · accession 0000899243-15-002428
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George K Ng
Officer — See Remarks
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2015 | P | 11,453 | $11.50 | A | 14,901 | I | Through Peng Ventures, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were issued pursuant to achievement of milestone in Agreement of Merger among Sorrento Therapeutics, Inc., STI Merger Sub, Inc. and IgDraSol, Inc. dated as of September 9, 2013.
Remarks
Executive Vice President & Chief Legal Officer